Global Branded Generics Market Report 2022: Growing Potential in Emerging Markets Creates Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 21, 2022--

The "Global Branded Generics Market (2022-2027) by Product, Applications, Distribution Channel, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Branded Generics Market is estimated to be worth USD 361 million in 2022, and is expected to reach USD 755.61 million by 2027, growing at a CAGR of 15.92%.

Market Segmentation

The Global Branded Generics Market is segmented based on Product, Applications, Distribution Channel, and Geography.

• By Product, the market is classified into Trade Named Generics, and Value-Added.
• By Applications, the market is classified into Anti-Cancer, Anti-Infective, Cardiovascular, CNS, and Others.
• By Distribution Channel, the market is classified into Hospital Pharmacy, Pharmacy, and Others.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Amneal Pharmaceuticals, Apotex, AstraZeneca, Aurobindo Pharma, Bausch Health Companies, Cadila Healthcare, Cipla, Dr. Reddy's Laboratories, etc.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

The Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Branded Generics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The Global Branded Generics Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.

Market Dynamics

Drivers

• Off-Invoice Discounts on Pharma Products
• Lipid-Lowering Branded Generics With Rising Obesity
• Increasing Prevalence of Chronic Disease & Cancer Along With Aging Population
• Patent Expiry of Major Branded Drugs
• Conducive Regulatory Environment

Restraints

• MisApplications of Risk Evaluation and Mitigation Strategies
• Increasing Price Pressure from Payer

Opportunities

• Growing Potential in Emerging Markets
• Conducive Environment in Developing Markets
• R&D Investments by Pharma Companies

Challenges

• Limited Penetration Associated Generic Drugs

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Branded Generics Market, by Product

7 Global Branded Generics Market, by Applications

8 Global Branded Generics Market, by Distribution Channel

9 Americas' Branded Generics Market

10 Europe's Branded Generics Market

11 Middle East and Africa's Branded Generics Market

12 APAC's Branded Generics Market

13 Competitive Landscape

14 Company Profiles

15 Appendix

Companies Mentioned

• Amneal Pharmaceuticals
• Apotex
• AstraZeneca
• Aurobindo Pharma
• Bausch Health Companies
• Cadila Healthcare
• Cipla
• Dr. Reddy's Laboratories
• Endo International
• Eris Lifesciences
• Eva Pharma
• GlaxoSmithKline
• Glenmark Pharmaceuticals
• Hetero
• Lupin Pharmaceuticals
• Mylan
• Novartis International
• Pfizer
• Sandoz International
• Sanofi
• STADA Arzneimittel
• Strides Arcolab
• Sun Pharmaceutical Industries
• Teva Pharmaceutical Industries
• Torrent Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/e8k5ie

View source version on businesswire.com:https://www.businesswire.com/news/home/20220921005703/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2022.